Stay updated on Phase 2 AMEERA-4 Clinical Trial
Sign up to get notified when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.

Latest updates to the Phase 2 AMEERA-4 Clinical Trial page
- Check7 days agoChange DetectedThe site revision label was updated from v3.4.1 to v3.4.2; no changes to study details or page behavior are visible.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedGlossary display is now visible on the page, and the revision tag has been updated to v3.4.0. The QC criteria and FEAR Act-related labels have been updated: 'Last Update Submitted that Met QC Criteria' was added and 'Last Update Submitted that met QC Criteria' removed, while 'No FEAR Act Data' was added and 'No FEAR Act data' removed.SummaryDifference0.2%

- Check36 days agoChange Detected- Page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's Locations section was updated to add general location categories and remove specific location groupings, indicating a reorganization of where sites are listed for the study.SummaryDifference0.6%

- Check86 days agoChange DetectedPublication notes in the Study Publications section were updated to clarify that entries are automatically pulled from PubMed and may not all relate to the study. The revision updates the wording from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Phase 2 AMEERA-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.